Prajakta A. Shinde

Mumbai, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Original Article | Immunohistochemical Expression of BCL2 (B cell lymphoma 2) in Invasive Breast Carcinoma and its Correlation with Clinicopathological Parameters.

Original Article | Immunohistochemical Expression of BCL2 (B cell lymphoma 2) in Invasive Breast Carcinoma and its Correlation with Clinicopathological Parameters.

Journal: The Gulf journal of oncology

Published: March 28, 2026

Digital Stethoscope-Derived Single-Lead Electrocardiogram and Artificial Intelligence to Detect Low Ejection Fraction: A Multicenter Observational Study.

Digital Stethoscope-Derived Single-Lead Electrocardiogram and Artificial Intelligence to Detect Low Ejection Fraction: A Multicenter Observational Study.

Journal: Journal of cardiothoracic and vascular anesthesia

Published: October 23, 2025

Mechanistic Insights and Emerging Applications of Nanogel-Based Topical Drug Delivery Systems.

Mechanistic Insights and Emerging Applications of Nanogel-Based Topical Drug Delivery Systems.

Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology

Published: May 19, 2025

Oncocytic variant of adrenocortical carcinoma: A rare entity.

Oncocytic variant of adrenocortical carcinoma: A rare entity.

Journal: Indian journal of cancer

Published: August 10, 2022

Immunohistochemical Study of p16INK4A, MIB-1 and CK17 in Pre-neoplastic and Neoplastic Epithelial Lesions of Cervix.

Immunohistochemical Study of p16INK4A, MIB-1 and CK17 in Pre-neoplastic and Neoplastic Epithelial Lesions of Cervix.

Journal: The Gulf journal of oncology

Published: August 14, 2021

Curcumin restores the engraftment capacity of aged hematopoietic stem cells and also reduces PD-1 expression on cytotoxic T cells.

Curcumin restores the engraftment capacity of aged hematopoietic stem cells and also reduces PD-1 expression on cytotoxic T cells.

Journal: Journal of tissue engineering and regenerative medicine

Published: October 24, 2019

Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients.

Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients.

Journal: Frontiers in immunology

Published: December 13, 2018

Freezing of dendritic cells with trehalose as an additive in the conventional freezing medium results in improved recovery after cryopreservation.

Freezing of dendritic cells with trehalose as an additive in the conventional freezing medium results in improved recovery after cryopreservation.

Journal: Transfusion

Published: August 01, 2018

Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy.

Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy.

Journal: Scientific reports

Published: January 02, 2018

Establishment of human iPSC line NCCSi003-A from CD34+cells of peripheral blood collected during apheresis of healthy donor from Indian ethnicity.

Establishment of human iPSC line NCCSi003-A from CD34+cells of peripheral blood collected during apheresis of healthy donor from Indian ethnicity.

Journal: Stem cell research

Published: December 05, 2017

Derivation of human iPSC line NCCSi002-A from umbilical cord blood (UCB) CD34+cells of donor from Indian ethnicity.

Derivation of human iPSC line NCCSi002-A from umbilical cord blood (UCB) CD34+cells of donor from Indian ethnicity.

Journal: Stem cell research

Published: November 09, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026